1. Home
  2. PACB vs TECX Comparison

PACB vs TECX Comparison

Compare PACB & TECX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pacific Biosciences of California Inc.

PACB

Pacific Biosciences of California Inc.

N/A

Current Price

$1.31

Market Cap

462.8M

Sector

Industrials

ML Signal

N/A

Logo Tectonic Therapeutic Inc.

TECX

Tectonic Therapeutic Inc.

HOLD

Current Price

$30.54

Market Cap

549.5M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
PACB
TECX
Founded
2000
2019
Country
United States
United States
Employees
N/A
60
Industry
Biotechnology: Laboratory Analytical Instruments
Sector
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
462.8M
549.5M
IPO Year
2010
N/A

Fundamental Metrics

Financial Performance
Metric
PACB
TECX
Price
$1.31
$30.54
Analyst Decision
Hold
Strong Buy
Analyst Count
3
5
Target Price
$1.67
$75.20
AVG Volume (30 Days)
5.5M
134.9K
Earning Date
05-07-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$93,468,000.00
N/A
Revenue This Year
$11.32
N/A
Revenue Next Year
$12.14
N/A
P/E Ratio
N/A
N/A
Revenue Growth
3.04
N/A
52 Week Low
$1.09
$14.39
52 Week High
$2.73
$35.99

Technical Indicators

Market Signals
Indicator
PACB
TECX
Relative Strength Index (RSI) 45.61 56.96
Support Level $1.18 $27.31
Resistance Level $1.34 $31.39
Average True Range (ATR) 0.10 1.83
MACD -0.01 0.15
Stochastic Oscillator 7.37 83.29

Price Performance

Historical Comparison
PACB
TECX

About PACB Pacific Biosciences of California Inc.

Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Europe Middle East, and Africa and Asia-Pacific.

About TECX Tectonic Therapeutic Inc.

Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. The company focuses on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.

Share on Social Networks: